Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Enxiao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5225-0173; OpenAlex author ID A5004295637. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers

Papers 3

  1. DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. Last author DOI 10.1111/jgh.14912↗
  2. Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer. Last author DOI 10.3892/or.2020.7499↗
  3. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling. Co-author DOI 10.1016/j.cbi.2019.02.026↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Liang · 2 shared papers, 2020 · strength 0.31
  2. Lu Bai · 2 shared papers, 2020 · strength 0.31
  3. Li Feng · 1 shared paper, 2019 · strength 0.11
  4. Jing Liang · 1 shared paper, 2019 · strength 0.11
  5. Yongcun Liu · 1 shared paper, 2019 · strength 0.11
  6. Lei Zhang · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.